XML 34 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statement of Cash Flows Statement (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income/(loss) attributable to the Company $ 14,396 $ 6,223
Adjustments to arrive at net income from continuing operations [Abstract]    
Net income attributable to noncontrolling interests 1,551 1,301
Net (income)/loss from discontinued operations (3,186) (1,545)
Net income/(loss) from continuing operations 12,761 5,979
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:    
Depreciation and amortization 9,516 8,591
Net income attributable to noncontrolling interests (1,551) (1,301)
Equity issued as compensation 3,249 2,367
Provision for loan losses 11,160 22,577
Loans originated for sale (42,775) (76,077)
Proceeds from sale of loans held for sale 47,280 79,293
Gain on the repurchase of debt (1,838) 0
Decrease/(increase) in income tax receivable and deferred 1,478 (18,121)
Net decrease/(increase) in other operating activities 2,625 (4,327)
Net cash provided by/(used in) operating activities of continuing operations 41,905 18,981
Net cash provided by/(used in) operating activities of discontinued operations 3,186 1,545
Net cash provided by/(used in) operating activities 45,091 20,526
Investment securities available for sale:    
Purchases (354,002) (388,262)
Sales 128,931 366,636
Maturities, redemptions, and principal payments 230,301 181,360
Purchases 0 (9,001)
Maturities, sales, and principal payments 0 10,507
(Investments)/distributions in trusts, net (271) (164)
(Purchase)/ redemption of Federal Home Loan Banks stock 1,061 549
Net (increase)/ decrease in portfolio loans 51,266 (216,464)
Proceeds from sale of OREO 8,516 10,217
Proceeds from sale and repayments of non-strategic loan portfolio 1,000 184
Capital expenditures, net of sale proceeds (3,924) (2,152)
Cash received from dispositions/ (paid for acquisitions, including deferred acquisition obligations, net of cash acquired) 586 (29,691)
Net cash provided by/(used in) investing activities 63,464 (76,281)
Cash flows from financing activities:    
Net increase in deposits 64,593 125,574
Net (decrease)/increase in securities sold under agreements to repurchase and other (136,150) (133,103)
Net (decrease)/increase in federal funds purchased 0 30,000
Net (decrease)/increase in short-term Federal Home Loan Bank borrowings (10,000) 0
Advances of long-term Federal Home Loan Bank borrowings 73,708 46,040
Repayments of long-term Federal Home Loan Bank borrowings (115,695) (95,432)
Repurchase of debt (3,000) 0
Net proceeds from issuance/ (paid for repurchase) of Series C Preferred stock 0 (154,000)
Dividends paid to common stockholders (1,540) (1,378)
Dividends paid to preferred stockholders (145) (2,954)
Tax deficiency from certain stock compensation awards (1,484) (974)
Proceeds from stock option exercises 161 44
Proceeds from issuance of common stock, net 591 27,473
Other equity adjustments (1,478) 2,794
Net cash provided by/(used in) financing activities (130,439) (155,916)
Net increase/(decrease) in cash and cash equivalents (21,884) (211,671)
Cash and cash equivalents at beginning of period 494,439 447,460
Cash and cash equivalents at end of period 472,555 235,789
Supplementary schedule of non-cash investing and financing activities:    
Cash paid for interest 25,710 39,765
Cash paid for income taxes, net of (refunds received) 11,258 21,113
Change in unrealized gain/ (loss) on securities available for sale, net 2,572 1,619
Change in unrealized gain/ (loss) on cash flow hedges, net (564) (1,274)
Change in unrealized gain/ (loss) on other, net 44 1
Held to maturity investments transferred to available for sale or other investments at amortized cost 2,515 0
Loans transferred into other real estate owned from held for sale or portfolio 8,921 7,379
Loans transferred into/(out of) held for sale from/(to) portfolio (526) 0
Equity issued for acquisitions, including deferred acquisition obligations 4,290 3,303
Equity receivable related to June 18, 2010 investment agreement with Carlyle $ 0 $ 6,268